A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
Vous n'êtes pas connecté
Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary supplements.
A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
March 5, 2025 -- A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and...
Choose a clinical condition from the list below that is applicable to your practice area or clinical interests. Assess the linked clinical practice...
A new investigational drug, berberine ursodeoxycholate (HTD1801), has been found to lower blood sugar, improve cholesterol levels, and enhance liver...
Researchers have discovered that the bAsah1 gene plays a vital role in preventing nonalcoholic fatty liver disease (NAFLD) /b from progressing into...
Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the need for valve...
The bite of a Gila monster is venomous enough to harm a human, but hidden within its toxic cocktail lies a life-changing discovery: the foundation of...
Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.
Businesses are still struggling with cost overruns and inefficiencies that stem from treating cloud purely as an IT function. Cloud optimisation is as...
Maintaining mitochondrial DNA (mtDNA) integrity is crucial for cardiomyocyte function, and its disruption plays a significant role in...